
Results
15
15 companies
Emcure Pharmaceuticals
Market Cap: ₹355.3b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,873.90
7D
-6.1%
1Y
28.9%
Ajanta Pharma
Market Cap: ₹464.5b
A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
AJANTPHARM
₹3,718.20
7D
6.0%
1Y
38.2%
Neuland Laboratories
Market Cap: ₹303.7b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹23,672.45
7D
6.7%
1Y
74.9%
Acutaas Chemicals
Market Cap: ₹261.8b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹3,198.20
7D
-2.6%
1Y
140.4%
Granules India
Market Cap: ₹213.6b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.
532482
₹861.80
7D
0.8%
1Y
86.8%
Lupin
Market Cap: ₹1.0t
Operates as a pharmaceutical company in India, the United States, and internationally.
500257
₹2,259.20
7D
-0.7%
1Y
14.7%
Ipca Laboratories
Market Cap: ₹478.1b
An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India.
IPCALAB
₹1,884.60
7D
11.8%
1Y
36.2%
Sai Life Sciences
Market Cap: ₹300.4b
Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.
SAILIFE
₹1,416.40
7D
-0.7%
1Y
57.4%
Aether Industries
Market Cap: ₹213.1b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹1,605.70
7D
0.5%
1Y
113.9%
Aurobindo Pharma
Market Cap: ₹936.3b
A pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally.
AUROPHARMA
₹1,627.20
7D
-1.3%
1Y
49.4%
Rubicon Research
Market Cap: ₹297.7b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹1,798.70
7D
12.7%
1Y
n/a
Abbott India
Market Cap: ₹572.3b
Operates as a pharmaceutical company in India.
500488
₹26,933.65
7D
-2.2%
1Y
-17.5%
Anthem Biosciences
Market Cap: ₹505.7b
Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.
ANTHEM
₹898.00
7D
5.3%
1Y
12.2%
Biocon
Market Cap: ₹667.2b
Manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally.
BIOCON
₹412.00
7D
-3.3%
1Y
13.1%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹457.4b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,699.80
7D
3.8%
1Y
-3.2%